Interleukin-17 regulation: an attractive therapeutic approach for asthma
about
Update on anticytokine treatment for asthmaEmerging targets in lipid-based therapyExpression of mRNA IL-17F and sIL-17F in atopic asthma patients.The flavonoid cyanidin blocks binding of the cytokine interleukin-17A to the IL-17RA subunit to alleviate inflammation in vivo.The effect of serine protease inhibitors on airway inflammation in a chronic allergen-induced asthma mouse model.Targeting interleukin-4 in asthma: lost in translation?Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice.Refractory asthma: mechanisms, targets, and therapy.Terminal arteriolar network structure/function and plasma cytokine levels in db/db and ob/ob mouse skeletal muscle.In vivo and in vitro studies of Th17 response to specific immunotherapy in house dust mite-induced allergic rhinitis patientsReduction of Airway Hyperresponsiveness by KWLL in Dermatophagoides-pteronyssinus-Challenged MiceAssociation of macrophage migration inhibitory factor promoter polymorphism -173G/C with susceptibility to childhood asthma.Gene therapy for allergic airway diseases.Chlamydophila pneumoniae re-infection triggers the production of IL-17A and IL-17E, important regulators of airway inflammation.Therapeutical measures to control airway tolerance in asthma and lung cancer.Blocking interleukin-17 attenuates enhanced inflammation by staphylococcal enterotoxin B in murine allergic rhinitis model.Role of bombesin receptor activated protein in the antigen presentation by human bronchial epithelial cells.Human eosinophils release IL-1ß and increase expression of IL-17A in activated CD4+ T lymphocytesIL-17A induces CCL28, supporting the chemotaxis of IgE-secreting B cells.Mind-body interactions in the regulation of airway inflammation in asthma: A PET study of acute and chronic stressCytokines in chronic respiratory diseases.Lipopolysaccharide inhibits Th2 lung inflammation induced by house dust mite allergens in mice.Correlation of cutaneous sensitivity and cytokine response in children with asthma.Heparin protects BALB/c mice from mite-induced airway allergic inflammation.Modulation of the IL-23/IL-17 axis by fenofibrate ameliorates the ovalbumin/lipopolysaccharide-induced airway inflammation and bronchial asthma in rats.Monoclonal Antibodies for the Management of Severe Asthma.Exogenous interleukin-17A inhibits eosinophil differentiation and alleviates allergic airway inflammation.Functional relevance of NLRP3 inflammasome-mediated interleukin (IL)-1β during acute allergic airway inflammation.Biologic Targeting: New and Effective Therapeutic Approaches against Severe Asthma.
P2860
Q27013617-71E7D26E-FDD8-4F65-A666-533066BB6F8DQ28655456-6ED01376-79FD-4A97-B73E-791EFF14D8C9Q33791913-400529FA-0DF4-4287-BC76-300094AF0067Q33922498-F29FA03E-CEFF-484C-8CF1-30261C4B178CQ34080204-EDA2935F-5871-4536-87C1-31ED28D41683Q34271232-B6EE7C47-6A3E-42F2-B114-6D85E5C81D3EQ34426614-927CB597-DA26-40B9-B0B8-EFE77E7B7096Q34788832-91011730-A97A-4877-81C8-F1AABDC5BC8CQ34842420-46C704FA-83EF-4969-88F2-92466B12776BQ35125226-DE257CFA-72BB-45AB-97D3-CB6E1E7CD1CBQ36702881-47737221-48CA-4F36-89A3-4CF5FF1FE699Q37399318-AE5DFA5A-CA62-453F-A50E-C78416AA7A7FQ37829670-2F844D67-CB4F-4BAF-B914-5CEACDE0609CQ37847149-C0CB3775-237E-442D-8AC9-97D07B240FAFQ38031462-159F349C-7B8F-49CF-807E-47329131303DQ38462275-33C955F1-318C-4B39-A201-E2B0DD27493CQ39289077-25B67C24-56FB-4F73-B485-1966D2438C1CQ39464920-75E64BC3-BAC1-41F7-AAAA-C0AEC35A2F11Q39568602-C595EC41-9D5D-4FC7-A005-CCC1E18FCEABQ39868533-90344C42-A31A-4034-98D0-EFD09AD031CDQ42113962-F9C2A904-91A9-4019-970E-C76A42BF3F5BQ44713506-52319A61-FDB5-4EE2-A388-B94C0E64A3D3Q47119032-D53A3DEE-3AD9-4C64-B0D6-FA4ECA68FBD3Q48463781-5B95619C-C095-4379-BC07-18136E79026CQ49484413-7594AE01-2F95-4C70-8FF1-F82B1DEB2985Q51687473-BD27EEBA-0986-487F-9234-95C3B06DC548Q51700318-C388A022-321C-43F0-AF45-842C0E1DA6E9Q51716028-AA76FCF6-5EFC-4982-9703-65E5B94E08DBQ52564875-E0D9CD1A-E526-4D10-894B-BB20653695C7
P2860
Interleukin-17 regulation: an attractive therapeutic approach for asthma
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Interleukin-17 regulation: an attractive therapeutic approach for asthma
@ast
Interleukin-17 regulation: an attractive therapeutic approach for asthma
@en
type
label
Interleukin-17 regulation: an attractive therapeutic approach for asthma
@ast
Interleukin-17 regulation: an attractive therapeutic approach for asthma
@en
prefLabel
Interleukin-17 regulation: an attractive therapeutic approach for asthma
@ast
Interleukin-17 regulation: an attractive therapeutic approach for asthma
@en
P2860
P921
P356
P1433
P1476
Interleukin-17 regulation: an attractive therapeutic approach for asthma
@en
P2093
Seoung Ju Park
Yong Chul Lee
P2860
P2888
P356
10.1186/1465-9921-11-78
P577
2010-06-16T00:00:00Z
P5875
P6179
1052479840